ENDRA Life Sciences (NDRA) Shares Outstanding (Diluted Average) (2023 - 2026)

ENDRA Life Sciences (NDRA) has 4 years of Shares Outstanding (Diluted Average) data on file, last reported at $1.2 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $1.2 million, up 115.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 115.14% YoY), and the FY2025 annual result was $787020.0, up 289.41% from the prior year.
• Shares Outstanding (Diluted Average) climbed to $1.2 million in Q1 2026 per NDRA's latest filing, from $787020.0 in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $1.2 million in Q1 2026 and troughed at $3636.0 in Q4 2023.
• A 4-year average of $536852.0 and a median of $557582.0 in 2025 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Diluted Average) surged 5458.47% in 2024, then jumped 115.14% in 2026.
• A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $3636.0 in 2023, then surged by 5458.47% to $202106.0 in 2024, then surged by 289.41% to $787020.0 in 2025, then surged by 52.42% to $1.2 million in 2026.
• Business Quant data shows NDRA's Shares Outstanding (Diluted Average) at $1.2 million in Q1 2026, $787020.0 in Q4 2025, and $761218.0 in Q3 2025.